Tomas Landh is since 2014 Innovation Sourcing VP and since 2025 Strategic Enterprise Strategy Expert in the Global BD/Search & Evaluation team. He was previously Director Strategy and Innovation Sourcing at Novo Nordisk, Diabetes Research. Tomas joined Novo Nordisk in 2003 and has more than 30 years of experience of all stages of drug development in various settings, from academia, small businesses, foundations and big pharma/biotech. He received his PhD in Biophysical Engineering from Lund’s Institute of Technology.